For patients with severe haemophilia A, studies provide both hints and an indication of an added benefit of prophylactic versus on-demand treatment with factor concentrates.
For patients with severe haemophilia A, studies provide both hints and an indication of an added benefit of prophylactic versus on-demand treatment with factor concentrates.